Dubai, UAE – Albatha Healthcare Group (Albatha Healthcare), one of the UAE’s leading integrated healthcare providers, has announced the strategic acquisition of Milab Scientific (Milab), a renowned medical and laboratory solutions company with over 40 years of regional experience. The acquisition marks a significant milestone in Albatha Healthcare’s ongoing mission to strengthen its presence across the diagnostics and laboratory sciences sector while driving innovation in healthcare delivery.
Founded more than four decades ago, Milab Scientific has established itself as a trusted name in molecular biology, genomics, proteomics, haematology, immunohistochemistry, and clinical and veterinary diagnostics. The company also supplies an extensive range of laboratory instruments, hospital equipment, and consumables, serving hospitals, research centers, and universities across the region.
“This acquisition reflects our ongoing commitment to advancing healthcare capabilities across the UAE and the wider region,” said Dr. Hesham Abdalla, Managing Director at Albatha Healthcare. “Milab’s deep technical expertise and proven track record in laboratory sciences perfectly complement our mission to foster innovation, improve diagnostic accuracy, and enhance patient outcomes.”
Anis Dadani, Director of Finance at Albatha Healthcare, added: “This strategic investment is a key part of our long-term growth strategy. By integrating Milab’s specialized expertise with Albatha Healthcare’s extensive operational network, we are poised to expand our footprint in advanced diagnostics, molecular biology, and laboratory solutions—delivering greater value to healthcare institutions and stakeholders alike.”
Reflecting on the partnership, Joshua Marchon, Business Unit Head at Milab Scientific, commented: “For more than 40 years, Milab has remained committed to delivering quality, service, and innovation. Becoming part of Albatha Healthcare enables us to extend our legacy, scale our impact, and offer next-generation scientific and diagnostic solutions to healthcare providers throughout the Middle East.”
Through this acquisition, Albatha Healthcare aims to accelerate innovation in diagnostics, broaden access to cutting-edge laboratory technologies, and empower medical institutions with enhanced capabilities for faster, more precise, and patient-centered care. The collaboration underscores Albatha Healthcare’s dedication to building a sustainable and innovative healthcare ecosystem that supports the UAE’s vision for medical excellence and regional leadership in health sciences.
